EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Stem cell therapies for spinal cord injury in humans: A review of recent clinical research

Keiko Sugai, Masaya Nakamura, Hideyuki Okano, Narihito Nagoshi

Brain and Spine · 2025 · 5 · 104207

DOI: 10.1016/j.bas.2025.104207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain and Spine, 2025. Verfasst von Keiko Sugai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, cell transplantation has emerged as a promising treatment for spinal cord injury (SCI). Over the past decade, numerous clinical studies of SCI have been conducted using various types of cells, including fetal neural stem/progenitor cells (NS/PCs), pluripotent stem cell-derived NS/PCs, mesenchymal stem/stromal cells (MSCs), olfactory ensheathing cells, and Schwann cells. Promising results have been reported for patients with subacute SCI, especially in studies involving MSCs, such as those conducted with Stemirac, although no universally recognized breakthroughs have been achieved. Allogenic NS/PCs may offer advantages over autologous MSCs because they have the potential for cell engraftment within the spinal cord and can be prepared in advance, facilitating their administration during the hyperacute phase. Recent advances achieved with induced pluripotent stem cells indicate their promise potential to be used in future therapies. This review provides an overview of recent clinical studies and discusses potential advancements anticipated in the future.

Schlagwörter

Stichwörter der Autor:innen

Clinical trialInduced pluripotent stem cellRegenerative medicineSpinal cord injuryStem cellTransplantation

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
  • Keio University Regenerative Medicine Research Center, Kanagawa, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Sugai, K., Nakamura, M., Okano, H., & Nagoshi, N. (2025). Stem cell therapies for spinal cord injury in humans: A review of recent clinical research. Brain and Spine, 5, 104207. https://doi.org/10.1016/j.bas.2025.104207

Vancouver

Sugai K, Nakamura M, Okano H, Nagoshi N. Stem cell therapies for spinal cord injury in humans: A review of recent clinical research. Brain and Spine. 2025;5:104207. doi:10.1016/j.bas.2025.104207

BibTeX
@article{Sugai2025,
  author = {Sugai, Keiko and Nakamura, Masaya and Okano, Hideyuki and Nagoshi, Narihito},
  title = {Stem cell therapies for spinal cord injury in humans: A review of recent clinical research},
  journal = {Brain and Spine},
  year = {2025},
  volume = {5},
  pages = {104207},
  doi = {10.1016/j.bas.2025.104207}
}
Kostenlos starten →